University Hospital of Brescia
Godfrey Grech is Senior Lecturer at the University of Malta and currently responsible for the National Breast Cancer Research Project. He is highly recognized by the clinical sector and runs numerous projects in collaboration with Mater Dei Hospital and International Institutions such as the Molecular Medicine Institute in Leeds. His main research topic aims to identify biomarkers to classify breast cancer patients into a specific therapeutic group that shall benefit from activation of phosphatases as a main therapeutic option. He is part of international scientific committees including the International Scientific Council of the European Group for Molecular Pathology (EMP), Global Leader at the Genomic Medicine within the National Human Genome Research Institute (NHGRI) of the US National Institutes of Health (NIH), member of the Pharmacogenomics Working Group of the Global Genomic Medicine Consortium (G2MC), Leader of the Cancer Position Paper at the European Association for Predictive, Preventive & Personalized Medicine (EPMA), and national contact point for the PharmacoGenetics for Every Nation Initiative (PGENI).